R3TA 30mg – 10 Vial Kit

Description

Retatrutide is a synthetic triple-agonist peptide targeting the GLP-1, GIP and glucagon receptors. It is a leading reference compound in metabolic and endocrine research.

Supplied by Vero Labs NZ as a 10-vial research kit (10 × 30mg vials of high-purity lyophilised powder) at bulk kit pricing. Batch certificate of analysis (COA) available on request. We also run independent third-party testing on selected batches and publish the results in full. Same-day dispatch, NZ-wide.

Research use only — not for human or animal consumption. This product is not intended to diagnose, treat, cure or prevent any disease. Sold only to qualified researchers.